FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental pharmacology and urology, and concerns preventing ischemia-reperfusion renal injuries. For this purpose, Wistar rats 120 minutes before simulating renal ischemia by applying non-traumatic clamps on renal pedicles for 40 minutes followed by reperfusion of blood flow, arginase II KUD975 inhibitor 3 mg/kg is administered intragastrically through a probe.
EFFECT: method provides effective prevention of renal ischemia-reperfusion injury, including due to endothelium-protective properties of the preparation administered at the experimentally established time.
1 cl, 1 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING RENAL ISCHEMIA REPERFUSION INJURY BY CARBAMYLATED DARBEPOETIN IN EXPERIMENT | 2018 |
|
RU2678768C1 |
METHOD FOR PREVENTING RENAL DYSFUNCTION WITH AN ARGINASE II INHIBITOR IN EXPERIMENT | 2018 |
|
RU2696580C1 |
METHOD FOR PREVENTING MICROCIRCULATION DISORDERS IN KIDNEYS WITH ASIALISED ERYTHROPOIETIN IN EXPERIMENT | 2018 |
|
RU2696864C1 |
METHOD FOR PREVENTING RENAL DYSFUNCTIONS WITH CARBAMYLATED DARBEPOETIN IN EXPERIMENT | 2018 |
|
RU2695334C1 |
METHOD FOR CORRECTING MICROCIRCULATION DISORDERS IN KIDNEY WITH INFLIXIMAB IN ISCHEMIA-REPERFUSION INJURY | 2021 |
|
RU2753247C1 |
METHOD FOR CORRECTING MICROCIRCULATION DISORDERS IN KIDNEY WITH PEPTIDE THAT MIMICS ALPHA-HELIX B OF ERYTHROPOIETIN IN ISCHEMIA-REPERFUSION INJURY | 2021 |
|
RU2751413C1 |
LITHIUM SALTS ADMINISTRATION FOR TREATING ACUTE RENAL INSUFFICIENCY | 2008 |
|
RU2409373C2 |
METHOD FOR CORRECTION OF ISCHEMIC DISORDERS CAUSED BY REPERFUSION LIVER INJURY | 2012 |
|
RU2479872C1 |
APPLYING (R)-IBUPROFEN METHANESULFONAMIDE AND ITS SALTS FOR TREATMENT AND PROPHYLAXIS OF REJECTION RESPONSE OF TRANSPLANTABLE ORGANS | 2002 |
|
RU2257895C2 |
METHOD OF AGENT APPLICATION BASED ON HUMAN MODIFIED PEROXYREDOXIN 2 FOR CORRECTING CONSEQUENCES OF ISCHEMIC-REPERFUSIVE KIDNEY DAMAGE | 2020 |
|
RU2747121C1 |
Authors
Dates
2019-07-23—Published
2018-09-24—Filed